The Apartment That Proved the Invisible Threat — Measured RF Levels in a Stockholm Home
In 2018, researchers measured extreme radiofrequency radiation levels inside a Stockholm apartment near base stations. The residents reported persistent symptoms. Here's what they found — and why it matters for every home near a cell tower.
Last reviewed: March 2026
Most conversations about electromagnetic radiation stay abstract. Frequency ranges. Regulatory thresholds. Animal models. Population studies.
This one doesn’t.
In 2018, Lennart Hardell, Michael Carlberg, and Lena Hedendahl published a case report in Oncology Letters that did something deceptively simple: they walked into a Stockholm apartment, placed a calibrated RF exposimeter, and measured what was actually there.
What they found was anything but simple.
The Setup
The apartment sat near two clusters of mobile phone base station antennas mounted on the roof of the building — one cluster located just 12 metres from the apartment balcony. The residents had been experiencing a range of persistent symptoms — headaches, difficulty concentrating, fatigue, sleep disturbances — that had worsened over time without any identifiable medical cause.
The researchers used an EME-Spy 200, a calibrated exposimeter manufactured by Satimo (MVG Industries), capable of measuring RF radiation across 20 predefined frequency bands. A total of 74,531 measurements were made across the apartment, corresponding to approximately 83 hours of recording.
The Findings
RF radiation levels inside the apartment were extraordinarily high — well above what most people assume they’re exposed to in a residential setting.
The total mean RF radiation level across the entire apartment was 3,811 µW/m², with a range of 15.2 to 112,318 µW/m². Particularly high levels were recorded on three balconies and in three of the four bedrooms. The highest mean level — 24,885.9 µW/m² — was measured on the balcony directly facing the base station cluster, just 12 metres away.
When the measured down-links from the base stations were excluded from the analysis, the total mean RF level dropped by 98% — confirming the towers as the dominant source.
The researchers concluded the apartment was “not suitable for long-term living, particularly for children who may be more sensitive than adults.”
Hardell L, Carlberg M, Hedendahl LK. “Radiofrequency radiation from nearby base stations gives high levels in an apartment in Stockholm, Sweden: A case report.” Oncology Letters. 2018; 15:7871–7883. DOI: 10.3892/ol.2018.8285
Why This Matters Beyond Stockholm
Every city has apartments like this one. Buildings with rooftop antennas. Homes within line-of-sight of cellular base stations. Offices flanked by broadcasting infrastructure. The difference between the Stockholm apartment and your living room may be one of degree, not kind.
Most people have never measured the RF environment in their home. They assume it’s within safe limits because they’ve never been told otherwise. But the limits they’re relying on were established based on thermal effects — the point at which RF energy physically heats tissue. Those thresholds were never designed to account for chronic, non-thermal, always-on exposure from multiple overlapping sources.
The Measurement Gap
Here’s the uncomfortable truth: you probably don’t know what your electromagnetic environment looks like. You know your air quality index. You know your water filtration rating. You might even know the VOC levels in your furniture.
But the RF field strength in your bedroom at 2 a.m.? The cumulative exposure your family absorbs from the router, the smart TV, the baby monitor, and the cell tower 300 metres away? That number doesn’t exist for most households. It’s the one metric nobody tracks — because nobody sees it.
The Stockholm study is a reminder that “invisible” doesn’t mean “absent.” And “unmeasured” doesn’t mean “safe.”
What Signal Hygiene Looks Like
You can’t relocate every cell tower. You can’t shield your home in a Faraday cage without cutting off the devices you depend on. The goal was never elimination — it’s suppression.
emGuarde works by generating precisely calibrated harmonic frequencies at 36, 72, 108, 144, and 180 MHz. These layered intervals target the disruptive character of ambient electromagnetic noise across the 3 MHz to 1,000 MHz range — without blocking Wi-Fi, cellular signals, or Bluetooth connectivity.
Place it on an elevated surface. Plug it in. That’s it. An 8-metre interference mitigation zone, operating continuously, silently, requiring no configuration.
For an in-depth look at how RF exposure affects sleep biology specifically, see Your Sleep Is Under Electromagnetic Siege →
Frequently Asked Questions
Q: How do I measure the RF levels in my home?
A calibrated RF exposimeter gives the most accurate readings across multiple frequency bands. Consumer-grade options like the Cornet ED88T or Trifield TF2 are accessible entry points for residential measurement.
Q: What are typical RF exposure levels in a residential home?
This varies significantly depending on proximity to cell towers, number of active devices, router placement, and building materials. The Stockholm case report demonstrated that residential exposure near base station antennas can reach mean levels of 3,811 µW/m² — far exceeding what most people assume.
Q: Does living near a cell tower mean my home has dangerous RF levels?
Proximity to base stations is one factor, but field strength depends on antenna direction, power output, building attenuation, and distance. The only way to know your actual exposure is to measure it.
Q: How is emGuarde different from RF shielding products?
Traditional shielding works by reflecting or absorbing incoming RF signals — which also blocks Wi-Fi, cellular data, and Bluetooth. emGuarde does not block signals. It generates precisely calibrated harmonic frequencies that suppress the disruptive character of ambient electromagnetic noise while leaving your devices fully connected.
emGuarde EM001 — The missing layer in your longevity stack. Launching June 2026.
Individual results may vary. Observations referenced in this article are based on published peer-reviewed research and do not constitute medical advice or a substitute for professional healthcare guidance.
References
- Hardell L, Carlberg M, Hedendahl LK. (2018). Oncology Letters; 15:7871–7883. DOI: 10.3892/ol.2018.8285